4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

764.29p
   
  • Change Today:
    -10.71p
  • 52 Week High: 1,390.00
  • 52 Week Low: 703.85
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 2
  • Market Cap: £118.76m

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,119,688 £8,557,615
Amy Walker 44,016 £336,408
Hansjörg Plaggemars 6,667 £50,955

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £39,129,464
DELPHI Unternehmensberatung AG 5,119,743 £39,129,464
4bb AG 5,115,852 £39,099,726
M&G Plc 4,627,741 £35,369,163
Elevage Medical Technologies Holdings 4,627,741 £35,369,163
Deutsche Balaton AG 4,432,637 £33,878,011
2invest AG 2,229,083 £17,036,563
Sparta AG 1,351,718 £10,330,988
Latonba AG 778,891 £5,952,953
Franciscus De Busschere 537,255 £4,106,163

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 764.29p
Change Today -10.71p
% Change -1.38 %
52 Week High 1,390.00
52 Week Low 703.85
Volume 2
Shares Issued 15.54m
Market Cap £118.76m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 06-Oct-2025

Time Volume / Share Price
08:00 2 @ 774.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page